Wuhan Mental Health Centre
14
2
2
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
7%
1 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique
Role: collaborator
Machine Learning-based Classification of Symptom Clusters and Online CBT
Role: lead
Multimodal Identification of Depressive Symptoms in the Elderly
Role: lead
Pragmatic Trial of Obsessive-compulsive Disorder
Role: collaborator
Home-Based Executive Function Training Intervention For Attention-Deficit/ Hyperactivity Disorder-prone Children
Role: lead
Internet-Based Behavioural Parent Training Intervention for Children With Attention Deficit/Hyperactivity Disorder
Role: lead
A Study for the Risky Decision-making Deficits Among Methamphetamine Dependence Individuals and Treatment
Role: collaborator
A Study on the Outcome and Its Influencing Factors in Patients With Borderline Personality Disorder
Role: lead
A Study of the Effectiveness of Electronic Interventions on the Standardized Prescription Benzodiazepines and Z-drugs
Role: collaborator
Early Identification and Predictive Parsing for High Risk Group of Schizophrenia
Role: lead
Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients
Role: collaborator
Randomized, Controlled Trial of an Intervention for Preschool Children With Autism: TEACCH
Role: lead
A Study of Thienorphine Hydrochloride Tablets in Relapse Prevention Treatment of Opioid Dependence
Role: collaborator
Multi-Dimensional Diagnosis,Individualized Therapy,and Management Technique for Major Depressive Disorder:Based on Clinical and Pathological Characteristics
Role: collaborator
All 14 trials loaded